Report Details:
15 Companies Covered
128 Pages
Electrophoresis Market Highlights
The Electrophoresis Market Size was estimated at 3.801 USD Billion in 2024. The Electrophoresis industry is projected to grow from USD 4.025 Billion in 2025 to USD 7.142 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025 - 2035.
Advances in life sciences research, notably in genomics, proteomics, and personalized medicine, are driving the industry, increasing demand for sophisticated analytical techniques such as electrophoresis.
Furthermore, the growing frequency of chronic diseases and genetic disorders around the world emphasizes the importance of reliable diagnostic tools, which is driving market expansion. Furthermore, the growing use of electrophoresis in drug development, quality control operations, and biopharmaceutical manufacturing provides lucrative potential for market expansion.
Overall, the confluence of technological breakthroughs and the growing emphasis on precision medicine are driving the electrophoresis market's rapid expansion.
MRFR recognizes the following companies as the key players in the global Electrophoresis market— Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. Inc. (US), QIAGEN N.V. (Netherlands), Lonza (Switzerland), Shimadzu Corporation (Japan), and HOEFER INC.(US).
Segment Analysis
The global Electrophoresis market has been segmented based on Product, application, and end user.
On the basis of Product, the market is segmented into Electrophoresis Reagents, Electrophoresis Systems, Gel Documentation Systems, and Electrophoresis Software.
The Electrophoresis Systems segment was attributed to holding the largest market share in 2024 because of ongoing technical advancements in electrophoresis equipment, which boost biomolecule separation and analysis's automation, efficiency, and accuracy. Additionally, the market is expanding due to the rising demand for electrophoresis systems in pharmaceutical, diagnostic, and research applications.
Based on application, the global Electrophoresis market has been segmented into Research Applications, Diagnostic Applications, and Quality Control & Process Validation.
The Research Applications segment was expected to hold the largest market share in 2024 attributed to many factors propelling market expansion, such as the rising breadth of genomes and proteomics research, higher investments in life sciences research and development, and expanding partnerships between academic institutions and pharmaceutical companies.
On the basis of End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, and Other End Users. The pharmaceutical and biotechnology companies segment was attributed to holding the largest market share in 2024 driven by a number of factors that support the market's expansion, such as the increased emphasis on personalized medicine, the need for better analytical methods for drug development, and the expansion of the biopharmaceutical pipeline.
The pharmaceutical and biotechnology industries employ electrophoresis methods extensively for a number of applications, such as protein analysis, nucleic acid separation, and quality control testing during the manufacturing process.
Regional Analysis
The global Electrophoresis market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Electrophoresis market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe.
The Electrophoresis market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Electrophoresis market comprises of Middle East, Africa, and Latin America.
North America appears as the largest region in the electrophoresis market, owing to significant investments in R&D, a well-established pharmaceutical sector, and a sophisticated healthcare infrastructure.
Europe is the second-largest area in the electrophoresis market, owing to increased government support for life sciences research, rising frequency of chronic diseases, and growing awareness of personalized treatment.
Asia-Pacific is the fastest-growing region in the electrophoresis market, thanks to rapid expansion in the pharmaceutical and biotechnology sectors, rising healthcare spending, and supporting government policies that encourage research and development.
Furthermore, the rest of the world's Electrophoresis market is divided into the Middle East, Africa, and Latin America. The rising acceptance of innovative healthcare technology, increased focus on research and development activities, and expanded collaborations with international companies in the life sciences industry are all factors contributing to the region's success.
Key Findings of the Study
- North America remains the largest market for electrophoresis, driven by robust research and development activities.
- The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising investments in biotechnology and healthcare.
- Electrophoresis Market reagents dominate the market, while electrophoresis systems are experiencing the fastest growth due to technological innovations.
- Key market drivers include technological advancements in electrophoresis and the rising demand in genomics, particularly in clinical diagnostics.
